MUMBAI - The clinical trials of Oxford-AstraZeneca's vaccine candidate for Covid-19 have been paused in India. The Serum Institute of India, which is conducting the clinical trials, announced the pause on Sept. 10. The Swedish-British pharmaceutical giant had declared a 'voluntary pause of vaccination' one day earlier after a volunteer developed an unexplained illness in […]
The post India Pauses Oxford-AstraZeneca’s Covid-19 Vaccine Trials appeared first on L.A. Focus Newspaper.
